Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

52 та иш

Иш: Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

  1. Hallmarks of Cancer: The Next Generation

    Douglas Hanahan, Robert A. Weinberg

    Шарҳ мақола201118 иқтибос
    ABI

  2. Tumor-Associated Macrophages: From Mechanisms to Therapy

    Roy Noy, Jeffrey W. Pollard

    Шарҳ мақола20145 иқтибос
    ABI

  3. Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

    Pengfei Zhao, Yonghui Wang, Xuejia Kang +7

    Мақола20184 иқтибос
    ABI

  4. Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

    Weimin Yin, Xiaolu Yu, Xuejia Kang +7

    Мақола20184 иқтибос
    ABI

  5. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

    Hairui Wang, Yisi Tang, Yuefei Fang +6

    Мақола20194 иқтибос
    ABI

  6. Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

    Huige Peng, Binfan Chen, Wei Huang +4

    Мақола20173 иқтибос
    ABI

  7. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

    Hongyue Jin, Yang He, Pengfei Zhao +4

    Мақола20183 иқтибос
    ABI

  8. Immunotherapy in colorectal cancer: rationale, challenges and potential

    Karuna Ganesh, Zsofia K. Stadler, Andrea Cercek +4

    Шарҳ мақола20193 иқтибос
    ABI

  9. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery

    Binfan Chen, Ang Gao, Bin Tu +7

    Мақола20203 иқтибос
    ABI

  10. Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity

    Pengfei Zhao, Jiaxin Zhang, Aihua Wu +8

    Мақола20203 иқтибос
    ABI

  11. Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy

    Pengfei Zhao, Weimin Yin, Aihua Wu +8

    Мақола20173 иқтибос
    ABI

  12. Fueling Immunity: Insights into Metabolism and Lymphocyte Function

    Erika L. Pearce, Maya C. Poffenberger, Chih‐Hao Chang +1

    Шарҳ мақола20132 иқтибос
    ABI

  13. Intraperitoneal Therapy for Peritoneal Cancer

    Ze Lu, Jie Wang, M. Guillaume Wientjes +1

    Шарҳ мақола20102 иқтибос
    ABI

  14. Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan

    W Chen, J Wang, Lianqun Jia +2

    Мақола20162 иқтибос
    ABI

  15. Lactic acid polarizes macrophages to a tumor-promoting state

    Oscar R. Colegio

    Мақола20152 иқтибос
    ABI

  16. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

    Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera +11

    Мақола20172 иқтибос
    ABI

  17. Histone Deacetylase Inhibitors as Anticancer Drugs

    Tomáš Eckschlager, Johana Plch, Marie Stiborová +1

    Шарҳ мақола20172 иқтибос
    ABI

  18. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

    Daniele V. F. Tauriello, Sergio Palomo‐Ponce, Diana Stork +15

    Мақола20182 иқтибос
    ABI

  19. Roles of Albumin‐Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery

    Pengfei Zhao, Yonghui Wang, Aihua Wu +2

    Шарҳ мақола20182 иқтибос
    ABI

  20. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer

    Samar M. Etman, Ossama Y. Abdallah, Radwa A. Mehanna +1

    Мақола20202 иқтибос
    ABI

  21. Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway

    Xinjian Xu, Ji Lv, Fang Guo +10

    Мақола20202 иқтибос
    ABI

  22. Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy

    Bin Tu, Meng Zhang, Tuanbing Liu +1

    Шарҳ мақола20202 иқтибос
    ABI

  23. Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy

    Zhidi He, Meng Zhang, Yonghui Wang +6

    Мақола20202 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI